home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

247 rows where filing_period = "third_quarter", filing_year = 2008 and issue_code = "PHA" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, income_amount, received_date (date)

issue_code 1

  • PHA · 247 ✖

filing_year 1

  • 2008 · 247 ✖

filing_period 1

  • third_quarter · 247 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
584208 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 88060b61-fcdb-4ca4-aea7-7a2e47d7d4ee Q3 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 86196 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2008 third_quarter PHA Monitor legislative developments in health care HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2008-03-23T11:31:28-04:00
584531 RUBICON ADVISORS, LLC 7f1c5857-b976-4b2b-b419-16e623cd0fd8 3A RUBICON ADVISORS, LLC 315091 TEVA PHARMACEUTICALS USA 2008 third_quarter PHA Patent Settlements H.R. 1432 S. 316, Generic Biologics S. 1695 H.R. 5629, Physician Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100   105000   0 0 2008-03-31T09:38:35-04:00
659334 DOW LOHNES GOVERNMENT STRATEGIES LLC 42d0a150-4cc1-44e4-851c-31c62e140239 3T DOW LOHNES GOVERNMENT STRATEGIES LLC 316013 APOTEX CORP 2008 third_quarter PHA H.R. 3700 Fair Medicaid Drug Payment Act of 2007, provisions related to regulation of generic drugs and consumer access; H.R. 1902 Protecting Consumer Access to Generic Drugs Act of 2007, all provisions related to generic drug consumer access; H.R. 3610 Food and Drug Import Safety Act of 2007, provisions related to drug safety. HOUSE OF REPRESENTATIVES,SENATE 10000   0 1 2008-09-04T17:27:19-04:00
659712 THE PETRIZZO GROUP, INC. 5f70b0c2-c3ef-4c82-a94c-cfdcebe5d7bb 3A THE PETRIZZO GROUP, INC. 305932 STRATUS PHARMACUETICALS INC 2008 third_quarter PHA FDA approval of papain products Food & Drug Administration (FDA) 10000   0 0 2008-09-26T11:30:52-04:00
660108 MARSHALL BRACHMAN e535d900-2b99-4643-96c0-ece1c0e885c9 Q3 MARSHALL BRACHMAN 6848 STEWART JACKSON PHARMACAL 2008 third_quarter PHA Senate HELP Committee and House Energy and Commerce Committee: monitor FDA legislation related to regulation of pharmaceutical manufacturing HOUSE OF REPRESENTATIVES,SENATE 6000   0 0 2008-10-01T13:29:14-04:00
660269 CYBER SECURITY RESEARCH CONSULTANTS, LLC 3d152d73-3959-418e-ac1f-b319a116e8fd Q3 CYBER SECURITY RESEARCH CONSULTANTS, LLC 91694 PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION 2008 third_quarter PHA Monitoring Dorgan-Snowe drug reimportation from Canada FY 09 Emergency Supplemental Appropriations HOUSE OF REPRESENTATIVES 10000   0 0 2008-10-02T13:57:04-04:00
660581 INDEPENDENT PHARMACY COOPERATIVE 3505f30f-c726-49ab-8f5f-2689d73b3fed Q3 INDEPENDENT PHARMACY COOPERATIVE 313098 INDEPENDENT PHARMACY COOPERATIVE 2008 third_quarter PHA H.R. 6331 "Medicare Improvements for Patients and Providers Act of 2008" H.R. 5839, Safeguarding Americas Pharmaceuticals Act Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2008-10-03T16:17:41-04:00
660790 STANTON PARK GROUP 94096c80-5621-4e77-b959-a22319b9810b Q3 STANTON PARK GROUP 83717 MCKESSON CORPATION AND ITS AFFILIATE US ONCOLOGY (FORMERLY US ONCOLOGY) 2008 third_quarter PHA Drug Safety issues; erythropoiesis stimulating agents (ESAs) safety and use HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2008-10-06T10:53:07-04:00
660805 STANTON PARK GROUP 2c5c2155-c924-4afb-b579-b15c3ddb27a0 Q3 STANTON PARK GROUP 83717 BARR LABORATORIES 2008 third_quarter PHA Generic Biologics, HR 1956; S. 1695; Hr 1038; S. 623; HR 5629; FDA Reform HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2008-10-06T11:00:11-04:00
660942 GO DADDY.COM 2c74d2cb-f863-42a6-817d-95e8e78feef4 Q3 GO DADDY.COM 303553 GO DADDY COM 2008 third_quarter PHA S. 980 Controlled Substances Act H.R. 6353, The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,Natl Telecommunications & Information Administration (NTIA),SENATE   169500 0 0 2008-10-06T14:23:04-04:00
661329 DUTKO WORLDWIDE, LLC 9557de25-bb99-4462-a362-296c0171ed21 Q3 DUTKO WORLDWIDE, LLC 12868 IBIS BIOSCIENCES 2008 third_quarter PHA Counsel and advise client regarding attempts to secure federal procurement contracts for biosensor device. Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) 10000   0 0 2008-10-07T12:55:16-04:00
661726 CARDENAS PARTNERS, LLC 591fcfc4-e2bc-4cd2-818a-6d67c3a3d98f 3T CARDENAS PARTNERS, LLC 284573 SCHERING CORPORATION 2008 third_quarter PHA Seeking U.S. Embassy support for American sales of pharmaceuticals in Latin America Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,State, Dept of (DOS) 50000   0 1 2008-10-08T13:30:20-04:00
661802 VENABLE LLP 1f28702e-9edc-43c2-9f05-512fde11c821 Q3 VENABLE LLP 39941 ENDO PHARMACEUTICALS INC 2008 third_quarter PHA General issues affecting the pharmaceutical industry. HOUSE OF REPRESENTATIVES,SENATE     0 0 2008-10-08T15:12:00-04:00
661993 DUTKO WORLDWIDE, LLC e500980b-18c8-4754-8b60-952f3bcb8924 Q3 DUTKO WORLDWIDE, LLC 12868 NEWAYS INTERNATIONAL 2008 third_quarter PHA Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly S. 762 Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2008-10-08T17:10:45-04:00
662256 HAMILTON ADVISORS INC. 594ed925-5537-4d3d-af47-7c151855924e 3A HAMILTON ADVISORS INC. 400306434 SANOFI-AVENTIS 2008 third_quarter PHA Medicare Never Events HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2008-10-09T11:13:57-04:00
662489 VAN FLEET ASSOCIATES 23c63a2d-60c9-4bc5-8c9a-5b66069b89e2 3T VAN FLEET ASSOCIATES 39781 KIRK PHARMACEUTICALS 2008 third_quarter PHA FDA, DEA regulations pertaining to over the counter drug sales.       0 1 2008-10-09T14:31:00-04:00
662578 TIMMONS AND COMPANY, INC. 48daef11-bc2f-49b9-a923-8be1b25d8d91 Q3 TIMMONS AND COMPANY, INC. 38164 TEVA PHARMACEUTICALS USA INC 2008 third_quarter PHA S. 28 - To amend title XVIII of the Social Security Act to require the use of generic drugs under the Medicare part D prescription drug program when available unless the brand name drug is determined to be medically necessary. S. 1505 - Affordable Biologics for Consumers Act. S. 1695 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, to promote innovation in the life sciences, and for other purposes. S. 242 - Pharmaceutical Market Access and Drug Safety Act of 2007. S. 251 - Pharmaceutical Market Access Act of 2007. S. 1082 - Prescription Drug User Fee Amendments of 2007. H.R. 2900 - Food and Drug Administration Amendments Act of 2007. H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act. H.R. 1038 - Access to Life-Saving Medicine Act. H.R. 5629 - Pathway for Biosimilars Act H.R. 3610 - Food and Drug Import Safety Act of 2007 H.R. 3624 - Consumer Food Safety Act of 2007 HOUSE OF REPRESENTATIVES,SENATE 100000   0 0 2008-10-09T15:16:56-04:00
662672 ANIMAL HEALTH INSTITUTE 00180b38-a5b2-4f42-9717-211f9b718da8 Q3 ANIMAL HEALTH INSTITUTE 4037 ANIMAL HEALTH INSTITUTE 2008 third_quarter PHA Animal drug and biologics regulation and approval process; Antibiotic Resistance; Animal Drug User Fee Act; HR 962 & S 549, Preservation of Antibiotics for Medical Treat Act of 2007; HR 2419, Farm, Nutrition, and Bioenergy Act of 2007; S 2302, Food And Energy Security Act of 2007; HR 3697 & S 2313, Strategies to Address Antimicrobial Resistance Act; HR 6432, Animal Drug User Fee Amendments Act of 2008 Agriculture, Dept of (USDA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   35000 0 0 2008-10-09T17:28:23-04:00
662677 WINBORN SOLUTIONS LLC 7b0589a5-b8c1-41a2-a624-f9b48af5a4d4 Q3 WINBORN SOLUTIONS LLC 308310 PERRIGO CO 2008 third_quarter PHA Food and drug safety, user fee, and country of origin legislation HOUSE OF REPRESENTATIVES,SENATE 18000   0 0 2008-10-09T17:40:27-04:00
662979 MR. JONATHAN BAND bbeb8284-cf3d-49aa-a567-3018018899cd Q3 MR. JONATHAN BAND 297215 NETCOALITION COM 2008 third_quarter PHA Online Pharmacies (Section 2(j) of S. 980) HOUSE OF REPRESENTATIVES,SENATE,U.S. Copyright Office,U.S. Trade Representative (USTR) 10000   0 0 2008-10-10T14:24:08-04:00
663101 LATHAM & WATKINS LLP 6202bc3e-0b95-4460-a2c2-b6da5ee67be6 Q3 LATHAM & WATKINS LLP 22201 AMPHASTAR PHARMACEUTICALS 2008 third_quarter PHA Congressional oversight of the Food and Drug Administration and Environmental Protection Agency EPA rulemaking on CFC propellants Environmental Protection Agency (EPA),Food & Drug Administration (FDA) 10000   0 0 2008-10-10T16:30:25-04:00
663103 LATHAM & WATKINS LLP c8bba92f-5725-4cf7-ba80-7b6a76a7f3ce Q3 LATHAM & WATKINS LLP 22201 ORCHID CHEMICALS & PHARMACEUTICALS LTD 2008 third_quarter PHA Food and Drug Administration policy. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2008-10-10T16:31:27-04:00
663230 INTERNATIONAL COMMERCE DEVELOPMENT CORP 42093032-0b66-4be6-b00e-1ecf8e219f6c Q3 INTERNATIONAL COMMERCE DEVELOPMENT CORP 286278 AMPHASTAR PHARMACEUTICALS INC 2008 third_quarter PHA Seeking generic pharmaceuticals approvals for client from the FDA and EPA. Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2008-10-11T19:44:55-04:00
663720 CROWELL & MORING LLP 803e8571-5a04-4805-a0f0-8429f4ab82b5 Q3 CROWELL & MORING LLP 11377 THE PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) 2008 third_quarter PHA Ensuring adequate and effective intellectual property rights for pharmaceutical products in non-U.S. markets. U.S. Trade Representative (USTR)     0 0 2008-10-13T13:27:58-04:00
663748 MICHAEL POLLARD 71c11771-6ef6-4dfd-815c-0d08df71824b Q3 MICHAEL POLLARD 87836 MEDCO HEALTH SOLUTIONS INC 2008 third_quarter PHA HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 6353 and S. 980 - Ryan Haight Online Pharmacy Consumer Protection Act of 2007; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 Access to Community Pharmacy Preservation Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c) S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects S 2161 - Community Pharmacy Fairness Act of 2007; all as Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE 50000   0 0 2008-10-13T14:04:13-04:00
663774 WINSTON & STRAWN LLP 953c8117-df42-435a-9d67-bdc150aef381 Q3 WINSTON & STRAWN LLP 41682 ABRAXIS BIOSCIENCE LLC 2008 third_quarter PHA Issues related to safety of breast cancer drugs HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2008-10-13T14:32:26-04:00
663795 WINSTON & STRAWN LLP 66b83779-df85-402a-b177-0d4358de1f69 Q3 WINSTON & STRAWN LLP 41682 BARR LABORATORIES INC 2008 third_quarter PHA Hatch - Waxman reform HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2008-10-13T14:47:33-04:00
664365 POLICY ADVOCATES 6f611bb6-c7bb-48d6-a609-c4a9f7a2c176 Q3 POLICY ADVOCATES 72018 PHOENIX CAPITAL MANAGEMENT LLC 2008 third_quarter PHA S.980: Online Pharmacy Consumer Protection Act of 2007 - Track and monitor. S.596: Safe Internet Pharmacy Act of 2007 - Track and monitor. S.554: Act For Our Kids - Track and monitor. HR 380: Pharmaceutical Market Access and Drug Safety Act of 2007 - Track and monitor. S. 242: Pharmaceutical Market Access and Drug Safety Act of 2007 - Track and monitor. H.R. 6353: Ryan Haight Online Pharmacy Consumer Protection Act of 2008 - Track and monitor. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2008-10-14T10:46:58-04:00
664396 MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY ddd33819-a9e7-43ef-9ca7-35438d96d4a6 Q3 MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY 62277 MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY 2008 third_quarter PHA H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicine Act of 2007, follow-on biologics H. R. 5629, Pathway for Biosimilars Act S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 623, Access to Life-Saving Medicine Act, follow-on biologics Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   340000 0 0 2008-10-14T10:56:45-04:00
664983 MR. THEODORE (TED) JONES 61a0427f-ca49-4de1-b56a-5b075106820b Q3 MR. THEODORE (TED) JONES 20926 PHARMACEUTICAL RESEARCH AND MANUFACTURES OF AMERICA 2008 third_quarter PHA Trade Association for certain Pharmaceutical Companies HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2008-10-14T14:44:19-04:00
664999 M.J. SIMON & COMPANY, LLC f1bb3027-e9db-44ba-8965-ce273f64b68e Q3 M.J. SIMON & COMPANY, LLC 40026223 BRAIDWOOD MANAGEMENT (FORM JEFFERSON CONSULT GP - HOTZE HEALTH CENTERS) 2008 third_quarter PHA Pharmacy Compounding HOUSE OF REPRESENTATIVES,SENATE 12500   0 0 2008-10-14T14:50:11-04:00
665159 BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC. 13af961a-d575-4b84-b609-987e08af8b9a Q3 BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC. 6382 BLUE CROSS AND BLUE SHIELD OF FLORIDA INC 2008 third_quarter PHA E-Prescribing: Effectiveness Research Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   320000 0 0 2008-10-14T15:32:52-04:00
665231 ALCALDE & FAY a97a120c-4c4d-49cc-bde6-e94388a0f3c6 Q3 ALCALDE & FAY 818 XSTREAM SYSTEMS, INC. 2008 third_quarter PHA Bringing awareness of the pharmaceutical authentication product to Committees of Congress and federal agencies. Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,Veterans Affairs, Dept of (VA) 30000   0 0 2008-10-14T15:45:22-04:00
665383 CML CONSULTING SERVICES INC. (FORMERLY L.A. SKIP BAFALIS) ef2e9a9b-fdb5-4668-8790-694d0d4aa9e9 Q3 CML CONSULTING SERVICES INC. (FORMERLY L.A. SKIP BAFALIS) 5062 ALCALDE & FAY (XSTREAM SYSTEMS INC ) 2008 third_quarter PHA Bringing awareness of the pharmaceutical authentication product to Committees of Congress and federal agencies. Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,Veterans Affairs, Dept of (VA) 10000   0 0 2008-10-14T16:17:18-04:00
665549 PARRY, ROMANI, DECONCINI & SYMMS 0d91c6de-72bc-4a73-ae80-9b079bd53eac Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 INTL ACADEMY OF COMPOUNDING PHARMACISTS 2008 third_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens (see next page). Support of H. Con. Res. 342, Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest. (Introduced in House), and Support of S. Con. Res. 88, Support of Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest. (Introduced in Senate) HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2008-10-14T18:09:09-04:00
665565 BROWNSTEIN HYATT FARBER SCHRECK, LLP b6f80c78-41bc-49c5-85ac-d1a56edca296 Q3 BROWNSTEIN HYATT FARBER SCHRECK, LLP 7257 NEUROMOLECULAR PHARMACEUTICALS 2008 third_quarter PHA Issues relating to pandemic influenza and governmental preparedness Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2008-10-14T18:33:33-04:00
665612 MEDCO HEALTH SOLUTIONS, INC 10f3d10c-6d18-4084-a140-28cc77997526 Q3 MEDCO HEALTH SOLUTIONS, INC 89177 MEDCO HEALTH SOLUTIONS INC 2008 third_quarter PHA Electronic Prescribing, Rule for Calculating Average Manufacturing Price for Prescription Drugs, Pharmacy Payments, Antitrust Exemption for Independent Pharmacies, Internet Pharmacies, Electronic Prescribing of Controlled Substances HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 6353 and S. 980 - Ryan Haight Online Pharmacy Consumer Protection Act of 2007; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 Access to Community Pharmacy Preservation Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c) S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects S 2161 - Community Pharmacy Fairness Act of 2007; all aspects Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Executive Office of the President (EOP),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   434097 0 0 2008-10-14T20:08:17-04:00
665974 M.J. SIMON & COMPANY, LLC d5523ef6-1a0c-444c-bfd4-e3c846af7c66 Q3 M.J. SIMON & COMPANY, LLC 40026223 WOMEN'S INTERNATIONAL PHARMACY INC (FORM JEFFERSON CONSULT GP - WOMEN'S INT) 2008 third_quarter PHA Pharmacy Compounding HOUSE OF REPRESENTATIVES,SENATE 12500   0 0 2008-10-15T10:52:03-04:00
666012 POLICY DIRECTIONS INC. 7d5c11fc-031c-4372-bf13-04f198c17671 Q3 POLICY DIRECTIONS INC. 31747 ALPHARMA INC/PFIZER ANIMAL HEALTH (FORMERLY KNOWN AS ALPHARMA INC ) 2008 third_quarter PHA Antibiotics in animal foods Drug approvals S. 549/HR 962, all titles, to end the use of certain antibiotics in animal feed if those antibiotics are used in human medicine. S. 2313/HR3697, all titles, to require the manufacturers of antibiotics used in animal feed to make certain reports to FDA. HR 3610 to reform FDA regulation of federal imported and domestic food safety with emphasis on those titles related to the import of ingredients for food and drugs, as well as country-of-origin labeling. Monitor legislative and regulatory developments related to the Animal Drug User Fee Act reauthorization, with related developments of the Generic Animal Drug UserFee Act. Monitor developments of the Food & Drug Administrations development of its Advanced Feed Safety System related to the use of animal drugs in livestock and poultry feeds. Agriculture, Dept of (USDA),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2008-10-15T11:06:00-04:00
666052 M.J. SIMON & COMPANY, LLC 8abcc845-4007-414e-abb3-65b7962f1a59 Q3 M.J. SIMON & COMPANY, LLC 40026223 WOMEN'S INTERNATIONAL PHARMACY INC (FORM JEFFERSON CONSULT GP - WOMEN'S INT) 2008 third_quarter PHA Pharmacy Compounding HOUSE OF REPRESENTATIVES,SENATE 12500   0 0 2008-10-15T11:14:25-04:00
666080 MARC ASSOCIATES, INC. c9462d84-8f53-4ec6-b031-b1ea37e793d1 Q3 MARC ASSOCIATES, INC. 23747 AMERICAN SOCIETY OF HEMATOLOGY 2008 third_quarter PHA Oncology drug issues. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2008-10-15T11:21:16-04:00
666166 BROYDRICK & ASSOCIATES a39f8350-74f0-4a8d-9871-2dce7c8571d1 Q3 BROYDRICK & ASSOCIATES 7268 BARR LABORATORIES 2008 third_quarter PHA Patent reform, Generic Biologies HOUSE OF REPRESENTATIVES,SENATE     0 0 2008-10-15T11:36:06-04:00
666182 AMERICAN CAPITOL GROUP 859c4325-4c10-4514-9d38-cf2940e8999e Q3 AMERICAN CAPITOL GROUP 305852 DISPENSING SOLUTIONS INC 2008 third_quarter PHA Drug Reimportation, Pharmacy, Counterfiet Drugs, HR 5839, the Safeguarding America's Pharmaceuticals Act HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2008-10-15T11:37:43-04:00
666188 MARC ASSOCIATES, INC. 27aadbc3-2bba-4d61-98d8-e6748099a53c Q3 MARC ASSOCIATES, INC. 23747 NATIONAL HEMOPHILIA FOUNDATION 2008 third_quarter PHA Blood and blood product safety. Issue related to blood product approvals. Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 40000   0 0 2008-10-15T11:38:45-04:00
666207 PARRY, ROMANI, DECONCINI & SYMMS 65136d4e-c791-4822-aa6c-4c45970fc7d3 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 WOMEN'S INTERNATIONAL PHARMACY, INC. 2008 third_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens (see next page). Support of H. Con. Res. 342, Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest. (Introduced in House), and Support of S. Con. Res. 88, Support of Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest. (Introduced in Senate) HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2008-10-15T11:41:27-04:00
666286 KEVIN MCGUINESS PLLC 461ff98a-eafd-4dae-b462-72a3322bba02 Q3 KEVIN MCGUINESS PLLC 299811 BARR LABS 2008 third_quarter PHA Issues that relate to legislation addressing the FDA, Bioshield, and generic biologics; S.623/H.R. 1032, Access to Life Saving Medicine Act HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2008-10-15T11:50:14-04:00
666352 UPS (UNITED PARCEL SERVICE) 7fca7d2f-e8d1-4e13-a055-672ef1f88b33 Q3 UPS (UNITED PARCEL SERVICE) 39223 UPS (UNITED PARCEL SERVICE) 2008 third_quarter PHA HR 5839 Safeguarding America's Pharmaceuticals Act of 2008 Pedigree - pharmaceutical distribution On-line Pharmacy Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Executive Office of the President (EOP),Federal Aviation Administration (FAA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Transportation Security Administration (TSA),U.S. Customs & Border Protection   1427517 0 0 2008-10-15T12:03:42-04:00
666700 THE UNITED STATES PHARMACOPEIAL CONVENTION 7cefd9bf-a1c5-450a-ac31-4d7f3c336b6a Q3 THE UNITED STATES PHARMACOPEIAL CONVENTION 400358632 THE UNITED STATES PHARMACOPEIAL CONVENTION 2008 third_quarter PHA -NO BILL NUMBER - Review revisions to FDA draft drug safety title, specific interest in the recognition of standards -S. 3396: Independent Drug Education Outreach Act of 2008, Regarding all provisions -S. 3408: Comparative Effectiveness Research Act of 2008, Regarding all provisions -Review draft legislation on medication errors HOUSE OF REPRESENTATIVES,SENATE   70000 0 0 2008-10-15T13:39:51-04:00
666868 TIMMONS AND COMPANY, INC. bd448ead-875f-4c19-9a33-71b81cf827bc Q3 TIMMONS AND COMPANY, INC. 38164 GO DADDY.COM 2008 third_quarter PHA H.R. 6353 - Ryan Haight Online Pharmacy Consumer Protection Act of 2008 HOUSE OF REPRESENTATIVES,SENATE 25000   0 0 2008-10-15T14:22:27-04:00
667074 AMERICAN COLLEGE OF CLINICAL PHARMACY cbe2917b-aee7-4a7b-a08b-b4410a5f09ff Q3 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2008 third_quarter PHA Coverage for direct patient care services of qualified pharmacists under Medicare Part B. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   55950 0 0 2008-10-15T14:55:32-04:00
667447 UNIVERSITY OF CONNECTICUT 142e2981-5f4f-4036-8c4d-0c92fe99bbe0 Q3 UNIVERSITY OF CONNECTICUT 39382 UNIVERSITY OF CONNECTICUT 2008 third_quarter PHA Implementation of Prescription Drug User Fee Amendments 2007 (Public Law 110-85), Drug safety related issues. H.R. 2900, Food and Drug Administration Amendments Act of 2007, Drug safety related issues. S. 3289/H.R. TBD, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2009, FDA salaries and expenses; and extramural research related issues. Defense, Dept of (DOD),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,Small Business Administration (SBA)   60000 0 0 2008-10-15T16:04:13-04:00
667548 AVENUE SOLUTIONS 2c87a2c3-e9c3-42aa-bfc0-8bc354094e75 Q3 AVENUE SOLUTIONS 72111 EXPRESS SCRIPTS INC 2008 third_quarter PHA Issues relating to prompt pay. HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2008-10-15T16:18:37-04:00
667568 AVENUE SOLUTIONS a18fac6e-b4bc-40a2-89ed-d8097b79c6ca Q3 AVENUE SOLUTIONS 72111 UNITEDHEALTH GROUP INC 2008 third_quarter PHA Issues relating to prompt pay. HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2008-10-15T16:21:52-04:00
667807 FOOD MARKETPLACE INC. 079f014f-42bb-46dd-a83f-e1b7d1f61ede Q3 FOOD MARKETPLACE INC. 15097 FOOD MARKETPLACE INC 2008 third_quarter PHA HR 6337, Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 - Title III, Privacy and Security Provisions - would require a patient's written consent before using their health information for certain purposes. HR 6331Medicare Patients and Providers Improvement Act - AMP - Provisions relating to retail pharmacy and Medicaid drug reimbursement (became public law 7/15/08) HR 5839, Safeguarding America's Pharmaceuticals Act - E-Pedigree mandates, enhanced wholesaler licensing, national uniform standards HR 970 and S. 2274, Dextromethorphan Distribution Act of 2007- prohibits sale of DXM products to persons under 18 years of age. HR 6898, Health-e Information Technology Act of 2008, Title IV, Privacy and Security Provisions - allows pharmacies to use protected health information for treatment, payment and healthcare operations. Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE   1600130 0 0 2008-10-15T17:00:36-04:00
667870 OMNICARE, INC. ddbf1a94-6ab9-40b2-a1e0-d816a3260547 Q3 OMNICARE, INC. 321112 OMNICARE INC 2008 third_quarter PHA Seeking clarifying information from Drug Enforcement Administration on emergency oral prescription policy Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,SENATE   89642 0 0 2008-10-15T17:23:00-04:00
667892 EXPRESS SCRIPTS, INC. d615c700-f96b-403d-b922-246453c351b2 Q3 EXPRESS SCRIPTS, INC. 294416 EXPRESS SCRIPTS, INC. 2008 third_quarter PHA HR 1038/HR 1956/S 1695/HR 5629--creation of a regulatory pathway for generic biologics S 1088/S 28/S 316/HR 1902--Issues related to bringing generics to market in a timely fashion S. 596/S. 980/HR 6353--internet pharmacy regulations HR 5839--issues relating to prescription drug pedigree/drug safety Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Executive Office of the President (EOP),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),SENATE   240000 0 0 2008-10-15T17:32:11-04:00
668107 AMERICA'S ESSENTIAL HOSPITALS 9ea9dcaa-a5cc-4e5e-ab3b-536bb30dc8c6 Q3 AMERICA'S ESSENTIAL HOSPITALS 27057 AMERICA'S ESSENTIAL HOSPITALS 2008 third_quarter PHA H.R. 2606 and S. 1376, 340B Program Improvement and Integrity Act of 2007 HOUSE OF REPRESENTATIVES,SENATE   90000 0 0 2008-10-15T19:11:33-04:00
668155 BROWNSTEIN HYATT FARBER SCHRECK, LLP 60cd6d20-2664-4f79-a1af-fe6eca33c37f Q3 BROWNSTEIN HYATT FARBER SCHRECK, LLP 7257 JOHNSON & JOHNSON SERVICES, INC. 2008 third_quarter PHA Follow-on Biologics Judicial Pay Controlled substances Pre-emption; legal reform S.1695-Biologics Price Competition and Innovation Act of 2007 S.1638-Federal Judicial Salary Restoration Act of 2007 H.R.3753-Federal Judicial Salary Restoration Act of 2007 S.1276-Methamphetamine Production Prevention Act of 2007 S.2274-Dextromethorphan Abuse Reduction Act of 2007 S.2450-To amend the Federal Rules of Evidence to address the waiver of the attorney-client privilege and the work product doctrine HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2008-10-15T21:15:30-04:00
668194 BROWNSTEIN HYATT FARBER SCHRECK, LLP 04ea3948-8493-4bc5-b1b2-ba2eae4f457d Q3 BROWNSTEIN HYATT FARBER SCHRECK, LLP 7257 SANOFI-AVENTIS US 2008 third_quarter PHA FDA drug approval process S.1695-Biologics Price Competition and Innovation Act   90000   0 0 2008-10-15T22:03:54-04:00
668820 PARRY, ROMANI, DECONCINI & SYMMS 82e71148-88c8-4191-904c-69f9d7e8aa94 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 BRAIDWOOD MANAGEMENT, INC. 2008 third_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens (see next page). Support of H. Con. Res. 342, Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest. (Introduced in House), and Support of S. Con. Res. 88, Support of Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest. (Introduced in Senate) HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2008-10-16T11:05:49-04:00
668957 PARRY, ROMANI, DECONCINI & SYMMS 916b297f-8e1a-4293-825f-c2a7a9bf67d7 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 SUNOVION PHARMACEUTICALS INC (FORMERLY SEPRACOR INC ) 2008 third_quarter PHA No specific legislation or bills introduced at this time. Medicare reimbursement issues. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2008-10-16T11:23:25-04:00
669079 GOODWIN PROCTER LLP 4572c897-14c0-4361-bacf-4207c1713aac Q3 GOODWIN PROCTER LLP 79756 TEVA PHARMACEUTICALS USA INC 2008 third_quarter PHA S.623 ACCESS TO LIFE SAVING MEDICINES ACT; H.R.1038 ACCESS TO LIFE SAVING MEDICINES ACT; S.1505 AFFORDABLE BIOLOGICS FOR CONSUMERS; S.1695 BIOLOGICS PRICE COMPETITION AND INNOVATION ACT OF 2007; H.R. 1956 THE PATIENT PROTECTION AND INNOVATIVE BIOLOGIC MEDICINE ACT (ALL PROVISIONS FOR ALL BILLS) HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2008-10-16T11:36:53-04:00
669233 FABIANI & COMPANY 10ec177c-d2b0-48c5-9b79-065e382b805e Q3 FABIANI & COMPANY 72576 ALNYLAM PHARMACEUTICALS 2008 third_quarter PHA S.1145 Patent Reform Act Provisions relating to the apportionment of damages HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2008-10-16T12:00:09-04:00
669489 SQUIRE PATTON BOGGS d39b5924-d390-4260-94a6-1e1ab4977fc0 Q3 SQUIRE PATTON BOGGS 30906 KERR CORPORATION 2008 third_quarter PHA FDA enforcement action against counterfeits of client's medical devices. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES 10000   0 0 2008-10-16T12:50:07-04:00
669721 SQUIRE PATTON BOGGS e9e3478f-6a66-4c3b-96a4-5f515d43b36f Q3 SQUIRE PATTON BOGGS 30906 SUNOVION PHARMACEUTICALS INC 2008 third_quarter PHA Issues related to inhalation drugs, including Xopenex. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2008-10-16T13:25:35-04:00
670162 FABIANI & COMPANY 8674e84b-4567-4cb9-b70b-bc9da3c3ea03 Q3 FABIANI & COMPANY 72576 VAXINNATE 2008 third_quarter PHA Department of Defense Appropriations Act of 2009, provisions relating to funding for novel flu vaccine development Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2008-10-16T14:22:24-04:00
670405 FABIANI & COMPANY 1c2ffef2-eddc-4d21-b6e7-c57fc278af64 Q3 FABIANI & COMPANY 72576 ACORDA THERAPEUTICS, INC. 2008 third_quarter PHA Educate members and staff about Acordas products. Secure funding through the annual appropriation process for research. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2008-10-16T14:46:40-04:00
670649 APOTEX CORP. d19044e0-3fdf-4a9f-bef6-39ec3fa46b66 Q3 APOTEX CORP. 310973 APOTEX CORP. 2008 third_quarter PHA S. 316, the Preserve Access to Affordable Pharmaceuticals Act HR 1902, the Protecting Consumer Access to Generic Drugs Act HR 1038, the Access to Life Savings Medicine Act HR 5629, the Pathway for Biosimilars Act S. 1695, the Biologics Price Competition and Innovation Act HR 5829, the Safeguarding America's Pharmaceuticals Act HR 3610, the Food and Drug Import Safety Act, Section 4 User Fees Regarding Drug Safety PL 110-85, the Foord and Drug Amendments Act of 2007, Section 914, Citizen Petition and petition for stay of agency action PL 110-85, the Food and Drug Amendments Act of 2007. Title VIII, Clinical Trial Databases HR 6432, Animal Drug User Fee Amendments of 2008, Section 301, Consideration of Certain Petitions Combating anti-generic substitution legislation in the states Abbreviated New Drug Application No. 76-396 for calcitonin salmon nasal spray HOUSE OF REPRESENTATIVES,SENATE   120000 0 0 2008-10-16T15:11:14-04:00
671124 UNIVERSITY OF PITTSBURGH MEDICAL CENTER fc29dd4b-8968-41f2-acbf-59acc8eab165 Q3 UNIVERSITY OF PITTSBURGH MEDICAL CENTER 32065 UNIVERSITY OF PITTSBURGH MEDICAL CENTER 2008 third_quarter PHA Issues related to the cost of prescription pharmaceuticals and the impact of that cost on hospitals and health care providers. Air Force, Dept of,Army, Dept of (Other),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   270000 0 0 2008-10-16T16:05:00-04:00
671265 NOVO NORDISK INC. cbbffa60-d002-4fb2-a72a-b68b1255c9b3 Q3 NOVO NORDISK INC. 284790 NOVO NORDISK INC. 2008 third_quarter PHA H.R. 3610, Foreign Facility FDA Inspection User Fees; H.R. 1585, National Defense Authorization (portions relating to Tricare); protecting patient access in S. 877, Controlling the Abuse of Prescriptions Act; S. 2029, Physician Payments Sunshine Act of 2007; S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Patent & Trademark Office (PTO),SENATE   300000 0 0 2008-10-16T16:24:39-04:00
671853 THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) 0f04a3b5-cf28-4cbd-8c76-6cc4776d7880 Q3 THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) 9237 THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) 2008 third_quarter PHA S.1505, Affordable Biologics for Consumers Act, issues relating to long term safety and effectiveness of medical devices and drugs. Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of   341435 0 0 2008-10-16T18:05:27-04:00
671996 VAN SCOYOC ASSOCIATES 4f05bf35-bfe4-4d19-872e-85364ffca86a Q3 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF CONNECTICUT 2008 third_quarter PHA Implementation of Prescription Drug User Fee Amendments 2007 (Public Law 110-85), Drug safety related issues. H.R.2900, Food and Drug Administration Amendemtns Act of 2007, Drug safety related issues. S.3289/H.R. TBD, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2009, FDA salaries and expenses; and extramural research related issues. Defense, Dept of (DOD),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,Small Business Administration (SBA) 50000   0 0 2008-10-16T18:49:14-04:00
672012 VAN SCOYOC ASSOCIATES 68bba4da-ad4d-454e-a65e-da43d0a47884 Q3 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF MARYLAND BALTIMORE 2008 third_quarter PHA Implementation of Prescription Drug User Fee Amendments, 2007 (PL 110-85), Drug safety related issues. H.R. 2900, Food and Drug Administration Amendments Act of 2007, drug safety related issues. S.3289/H.R. TBD, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2009, FDA salaries and expenses; and extramural research related issues. Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2008-10-16T18:54:19-04:00
672019 VAN SCOYOC ASSOCIATES 783784ae-3503-4183-8c9b-ec85f33020d8 Q3 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE 2008 third_quarter PHA S.3289/H.R. TBD, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2009, FDA and USDA funding initiatives. Implementation of Prescription Drug User Fee Amendments, 2007 (Public Law 110-85), Drug safety related issues. H.R. 3580, Food and Drug Administration Amendments Act of 2007, Drug safety and science related issues. Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2008-10-16T18:56:21-04:00
672429 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 61958dd1-55fd-4ccf-b5a8-699d0c2c1c2d Q3 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 26672 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 2008 third_quarter PHA See addendum. H.R.970, the Dextromethorphan Distribution Act, as related to the abuse of dextromethorphan. H.R.971, the Community Pharmacy Fairness Act, as related to provider negotiations in the Medicare program. H.R.1108, Family Smoking Prevention and Tobacco Control Act, as related to the regulation of the sale of tobacco products. H.R.1424, the Emergency Economic Stabilization Act of 2008, as related to fiscal sustainablity for healthcare services. H.R.1474, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act, as related to provider reimbursement in the Medicare program. H.R.3700, the Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program. H.R.4008, Credit and Debit Card Receipt Clarification Act of 2007, as related to fair credit card practices. H.R.5491, Emilys Act, as related to the certification of pharmacy technicians. H.R.5546, Credit Card Fair Fee Act of 2008, as related to fair credit card practices. H.R.5613, Protecting the Medicaid Safety Net Act of 2008, as related to provider participation in the Medicaid program. H.R.5658, Duncan Hunter National Defense Authorization Act for Fiscal Year 2009, as related to provider participation in the TRICARE program. H.R.5839, Safeguarding America's Pharmaceuticals Act of 2008, as related to drug safety and electronic tracking of pharmaceuticals. H.R.6353/S.980, Ryan Haight Online Pharmacy Consumer Protection Act of 2008, as related to online pharmacies. H.R.6357, PRO(TECH)T Act of 2008, as related to pharmacy involvement in health information technology. H.R. 6491/S.3434, the Organized Retail Crime Act of 2008, as related to the prosecution of organized theft. H.R. 6713, the E-Fencing Enforcement Act of 2008, as related to the prosecution of organized theft. H.R. 6831/S.3666, the Copper Theft Prevention Act of 2008 as related to theft and interstate fencing of stolen copper. H.R. 6898, the Health-e Information Technology Act of 2008 as related to pharmacy involvement in health information technolo… Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Office of Natl Drug Control Policy (NDCP),President of the U.S.,SENATE   300000 0 0 2008-10-17T09:39:46-04:00
672446 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 86323c24-1f83-4808-98cb-b271aa77da4e Q3 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 28776 HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) 2008 third_quarter PHA Importation of prescription drugs (H.R. 3161) (S. 1644) (S. 3409) Rx Pedigree (H.R. 5839) Methamphetamine/Pseudoephedrine Regulation (S. 2071) Internet Pharmacy (S. 980) (H.R. 6353) Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   140673 0 0 2008-10-17T09:44:25-04:00
672781 VORYS, SATER, SEYMOUR AND PEASE LLP 06f1896c-d966-4272-aa78-d157afe1da76 Q3 VORYS, SATER, SEYMOUR AND PEASE LLP 40236 SOLVAY PHARMACEUTICALS INC 2008 third_quarter PHA Implementation of national strategy to prepare for pandemic influenza. FY 2009 Labor, HHS appropriations bill S.3230 HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2008-10-17T10:35:19-04:00
672921 POLICY IMPACT COMMUNICATIONS, INC. 608efcb2-1a45-4d3a-b97d-0716325d0f69 Q3 POLICY IMPACT COMMUNICATIONS, INC. 31758 STRATEGIC APPLICATIONS INTERNATIONAL LLC 2008 third_quarter PHA Development of legislation to restore Medicaid benefits for mentally ill offenders. HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2008-10-17T10:45:31-04:00
673148 AARP 1d46f2c3-9c8b-4b3b-b4a6-c1a92cd4cee8 Q3 AARP 1694 AARP 2008 third_quarter PHA S 623/HR 1038 (Access to Life Saving Medicine Act), HR 1956 (Patient Protection and Innovative Biologic Medicines Act of 2007), HR 5629 (Pathway for Biosimilars Act) - Lobbied to ensure that Waxman Biogenerics legislation is enacted particularly provisions related to ensuring a safe, effective pathway for the approval of comparable, interchangeable biologics. HR 1902 (Protecting Consumer Access to Generic Drugs Act of 2007)/ S 316 (Preserve Access to Affordable Generics Act -Provisions related to preventing abuses in patent settlements between generic and brand name prescription drug manufactures. S 1145 Patient Reform Act of 2007- Ensuring that the existing inequitable conduct provisions in Patent Law Act are not weakened. Discussion regarding prescription drug affordability (no Bill). S 3230 Labor/HHS/Education Appropriations FY 2009 - Lobbying for spending levels for Rx comparative effectiveness. S 3289 Agriculture and Rural Development Appropriations, FY 2009 - Lobbied to reduce FDA generic drug processing backlog. Administration on Aging,Commerce, Dept of (DOC),Equal Employment Opportunity Commission (EEOC),Federal Communications Commission (FCC),Federal Reserve System,Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),SENATE,Social Security Administration (SSA),Treasury, Dept of,White House Office   7330000 0 0 2008-10-17T10:59:33-04:00
673318 CAPITOL HILL CONSULTING GROUP e2623d57-bfb4-44be-9c39-8631b3511694 Q3 CAPITOL HILL CONSULTING GROUP 72053 DFB PHARMACEUTICALS INC 2008 third_quarter PHA General Pharmaceutical Issues pertaining to the company. No specific legislation. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2008-10-17T11:16:14-04:00
673494 INDEPENDENCE BLUE CROSS 6eee542b-10cd-4014-a713-9e802b2fbb77 Q3 INDEPENDENCE BLUE CROSS 19172 INDEPENDENCE BLUE CROSS 2008 third_quarter PHA E-prescribing: Comparative Effectiveness Research: HR3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only; "Enhanced Health Care Value of All Act" Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE     0 0 2008-10-17T11:27:12-04:00
673839 RASKY PARTNERS, INC. 5702c24e-e0fa-44d6-8853-07cdaac0664d Q3 RASKY PARTNERS, INC. 297410 ELI LILLY AND CO 2008 third_quarter PHA HR 5629, Pathway for Biosimilars Act Legislation HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2008-10-17T11:57:03-04:00
673896 340B HEALTH 02994312-0148-47bc-92a3-ac97677edfb3 Q3 340B HEALTH 316434 340B HEALTH 2008 third_quarter PHA HR 2606 and S 1376. Extending 340B Drug Pricing to Inpatient Setting in DSH Hospitals and improving program integrity. Preserving current 340B Patient Definition Opposition to new regulations regarding physician administered drugs Centers For Medicare and Medicaid Services (CMS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE   161917 0 0 2008-10-17T12:00:43-04:00
673957 STUNTZ DAVIS & STAFFIER, P.C. aa0e6b73-ec09-4b22-8454-ee28d90891f1 Q3 STUNTZ DAVIS & STAFFIER, P.C. 37141 ASTRAZENECA PHARMACEUTICALS LP 2008 third_quarter PHA Drug importation: FDA foreign drug inspection program; Medicaid drug rebates; direct to consumer advertising of pharmaceuticals.   20000   0 0 2008-10-17T12:07:07-04:00
673978 CAPITOL HILL CONSULTING GROUP f3da6d95-4e34-436f-9685-de74c3596233 Q3 CAPITOL HILL CONSULTING GROUP 72053 PURDUE PHARMA LLP 2008 third_quarter PHA Controlled Drug Substances Act (21 USC 13) HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2008-10-17T12:08:53-04:00
674200 STUNTZ DAVIS & STAFFIER, P.C. f1c692dc-5b60-4bc8-9601-19f4894855ba Q3 STUNTZ DAVIS & STAFFIER, P.C. 37141 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 2008 third_quarter PHA Drug safety issues. Pharmaceutical user fees. Foreign drug inspections. Drug reimportation. Direct to consumer drug advertising.   10000   0 0 2008-10-17T12:30:21-04:00
674550 THE FRITTS GROUP d84a65ee-2f49-4959-a2c4-93d900de0841 Q3 THE FRITTS GROUP 309275 CBS 2008 third_quarter PHA H.R. 1561 - Enhancing Drug Safety and Innovation Act of 2007 HOUSE OF REPRESENTATIVES,SENATE 75000   0 0 2008-10-17T13:06:08-04:00
674569 THE FRITTS GROUP 53e100ce-073c-4277-a019-6d422b51aece Q3 THE FRITTS GROUP 309275 NEWS CORPORATION 2008 third_quarter PHA H.R. 1561 - Enhancing Drug Safety and Innovation Act of 2007 HOUSE OF REPRESENTATIVES,SENATE 75000   0 0 2008-10-17T13:08:16-04:00
674851 MCDERMOTT WILL & SCHULTE LLP e3b6f706-6120-40f8-b7c8-15b3b8c33864 Q3 MCDERMOTT WILL & SCHULTE LLP 24338 RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION 2008 third_quarter PHA Amendments to Section 340(b) of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2008-10-17T13:40:12-04:00
675034 DUANE MORRIS GOVERNMENT AFFAIRS f5dd6c1f-eb6f-473a-8bf9-619bbf24119c Q3 DUANE MORRIS GOVERNMENT AFFAIRS 49657 LEHIGH VALLEY TECHNOLOGIES 2008 third_quarter PHA Monitor Federal activity relating to pharmaceutical manufacturing. Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,SENATE     0 0 2008-10-17T13:53:56-04:00
675134 DUANE MORRIS GOVERNMENT AFFAIRS 2ac1b5b3-4a4e-455d-91a3-f12f6df6686f Q3 DUANE MORRIS GOVERNMENT AFFAIRS 49657 CB DISTRIBUTORS INC 2008 third_quarter PHA Regulation of over-the-counter asthma-cough medicines. Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2008-10-17T14:07:40-04:00
675404 BUCHANAN INGERSOLL & ROONEY PC d4f07a04-2965-4fb4-8f54-cc24f79a8f78 Q3 BUCHANAN INGERSOLL & ROONEY PC 55291 XOMA 2008 third_quarter PHA Biotechnology, Tax, Disaster Planning, Homeland Security, Science and Technology and Pharmacy issues within the U.S. House and U.S. Senate. Defense, Dept of (DOD),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) 60000   0 0 2008-10-17T14:28:19-04:00
675511 VAN NESS FELDMAN, LLP ad199697-cdfe-42e0-b71e-3d9a0e4368a1 Q3 VAN NESS FELDMAN, LLP 39815 MCKESSON CORPORATION 2008 third_quarter PHA S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007 S. 251, Pharmaceutical Market Access Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007 H.R. 5839, Safeguarding America's Pharmaceuticals Act S. 207, Combat Methamphetamine Enhancement Act of 2007 H.R. 971, Community Pharmacy Fairness Act of 2007 S. 885, Community Pharmacy Fairness Act of 2007 H.R. 3140, Saving Our Community Pharmacies Act of 2007 H.R. 3193, Access to Community Pharmacy Preservation Act of 2007 H.R. 780, Counterfeit Drug Prevention Act of 2007 S. 2085, Patient and Pharmacy Protection Act of 2007 H.R. 6353, Online Pharmacy Consumer Act S. 1954, Pharmacy Access Improvement Act of 2007 H.R. 5629, Pathway for Biosimilars Act H.R. 3610, Food and Drug Import Safety Act of 2007 H.R. 5619, Combat Methamphetamine Enhancement Act of 2008 Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2008-10-17T14:38:32-04:00
675554 HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY 168f8193-f8ab-4bb8-994d-c42c3e86e380 Q3 HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY 72793 HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY 2008 third_quarter PHA E-prescribing; Comparative Effectiveness Research: HR3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only; HR2184 "Enhanced Health Care Value for All Act" HOUSE OF REPRESENTATIVES,SENATE   20000 0 0 2008-10-17T14:44:46-04:00
675784 TARPLIN, DOWNS & YOUNG, LLC c213935f-6a84-4b54-8a34-52b9993146ac Q3 TARPLIN, DOWNS & YOUNG, LLC 304736 HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) 2008 third_quarter PHA **see addendum page Importation of prescription drugs (H.R. 3161) (S. 1644) Rx Pedigree (H.R. 5839) Methamphetamine/Pseudoephedrine Regulation (S. 2071) Internet Pharmacy (S. 980) (H.R. 6353) Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 60000   0 0 2008-10-17T15:04:41-04:00
675824 HANCE SCARBOROUGH 4968be84-9e09-47c1-ad96-07061dccf149 Q3 HANCE SCARBOROUGH 17443 ALLIANCE FOR PHARMACY COMPOUNDING 2008 third_quarter PHA Federal legislation affecting the practice of pharmacy and FDA regulation of compounded drugs. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2008-10-17T15:06:52-04:00
675955 BROWN RUDNICK LLP fbb674b9-fd54-4b65-835d-69bb28249baf Q3 BROWN RUDNICK LLP 287895 HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC 2008 third_quarter PHA H.R. 6353, Ryan Haight Online Pharmacy Consumer Protection Act of 2008 HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2008-10-17T15:13:21-04:00
676106 MENTAL HEALTH AMERICA a1385398-a284-412a-aa10-e0617edf6bbe Q3 MENTAL HEALTH AMERICA 28195 MENTAL HEALTH AMERICA 2008 third_quarter PHA Medicare Part D; Comparative effectiveness research legislation Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   24869 0 0 2008-10-17T15:23:51-04:00
676151 WALGREEN COMPANY 2715fcfa-f1cc-4f73-b6ae-7d6ad7885667 Q3 WALGREEN COMPANY 309071 WALGREEN COMPANY 2008 third_quarter PHA S.1951/H.R. 3700 Fair Medicaid Drug Payment Act of 2007 regarding Medicaid reimbursement for generic drugs as related to average manufacturers price (AMP) and federal upper limits (FULs); H.R. 3140 Saving Our Community Pharmacies Act of 2007 regarding Medicaid reimbursement of generic drugs as related to AMP and FULs; S. 334 Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; S.980/H... 6353 Online Pharmacy Consumer Protection Act of 2007 regarding amendments to the control substances act relating to the delivery of control substances over the internet; S.3101/H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 Sec. 132 regarding incentives for electronic prescribing, Sec. 171 regarding prompt pay by PDPs and MA-PDs for prescriptions dispensed in Medicare Part D, Sec. 203 regarding reimbursement for generic drugs dispensed in the Medicaid program; S. 2408 "E-Meds Act of 2007 regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 2900 Food and Drug Amendments Act of 2007 Sec. 910 regarding pharmaceutical safety; H.R. 5839 Safeguarding Americas Pharmaceuticals Act of 2008 regarding amending the Food, Drug & Cosmetics Act to improve the safety of drugs; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation; S. 3001/ H.R. 5658 National Defense Authorization Act for Fiscal Year 2009 Sec. 702 regarding a freeze on current copays at retail pharmacies for medications dispensed in the TRICARE pharmacy program; MedGuides regarding improvements needed to the Medication Guide program no specific legislation; S. 1693 Wired for Healthcare Quality Act of 2007- Title IV Sec 401 Privacy and Security regarding changes in the definition of marketing under HIPAA and breach notification; H.R. 6357 PRO(TECH)T Act of 2008 - T… Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office   320000 0 0 2008-10-17T15:26:05-04:00
676209 BLUE CROSS AND BLUE SHIELD ASSOCIATION ab07bcf0-f1eb-4db8-a6b6-ba6c5cf5d6e4 Q3 BLUE CROSS AND BLUE SHIELD ASSOCIATION 6358 BLUE CROSS AND BLUE SHIELD ASSOCIATION 2008 third_quarter PHA E-prescribing; Comparative Effectiveness Research: HR3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only; HR2184 "Enhanced Health Care Value for All Act" Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office   1800000 0 0 2008-10-17T15:31:26-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 1956.925ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API